US0378331005 - Common Stock - After market: 154.39 -0.11 (-0.07%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-02-03 | DA Davidson | Maintains | Buy |
2023-02-03 | Needham | Reiterate | Buy |
2023-02-03 | Rosenblatt | Maintains | Buy |
2023-02-03 | Barclays | Maintains | Equal-Weight |
2023-02-03 | Cowen & Co. | Maintains | Outperform |
2023-02-03 | Wedbush | Maintains | Outperform |
2023-02-03 | Raymond James | Maintains | Outperform |
2023-02-03 | JP Morgan | Maintains | Overweight |
2023-02-03 | Piper Sandler | Reiterate | Overweight |
2023-01-23 | Deutsche Bank | Maintains | Buy |
2023-01-19 | JP Morgan | Maintains | Overweight |
2023-01-18 | Canaccord Genuity | Maintains | Buy |
2023-01-13 | Rosenblatt | Maintains | Buy |
2023-01-11 | Barclays | Maintains | Equal-Weight |
2023-01-04 | Wedbush | Maintains | Outperform |
2023-01-03 | Exane BNP Paribas | Downgrade | Outperform -> Neutral |
2022-12-20 | JP Morgan | Maintains | Overweight |
2022-11-08 | UBS | Maintains | Buy |
2022-11-08 | Morgan Stanley | Maintains | Overweight |
2022-11-07 | Barclays | Maintains | Equal-Weight |
2022-11-07 | B of A Securities | Maintains | Neutral |
2022-10-28 | Deutsche Bank | Maintains | Buy |
2022-10-28 | Keybanc | Maintains | Overweight |
2022-10-28 | Barclays | Maintains | Equal-Weight |
2022-10-28 | Wedbush | Maintains | Outperform |
2022-10-28 | Credit Suisse | Maintains | Outperform |
2022-10-28 | Citigroup | Maintains | Buy |
2022-10-17 | Morgan Stanley | Maintains | Overweight |
2022-10-13 | Credit Suisse | Maintains | Outperform |
2022-10-11 | Barclays | Maintains | Equal-Weight |
Find the competitors with the best analyst ratings on the USA